mRNA m 6 A modifications and the RNA-binding protein YTHDF1 affect translational control in both normal and pathological learning
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2518250123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Zhuoyue Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, The University of Chicago, Chicago, IL 60637. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Protein Biosynthesis, RNA, Messenger, Learning. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, HHS | NIH | National Institute on Drug Abuse (NIDA).
Abstract (Originalsprache)
Animals learn and adapt to environmental changes. However, neural plasticity can also become maladaptive, leading to neurological and psychiatric disorders. How do we use known molecular mechanisms to harness the power of neural plasticity to prevent and treat diseases? Consolidating learning is known to require new protein synthesis. We found that mRNA m 6 A modifications and the RNA-binding protein YTHDF1 are required for molecular, cellular, and behavioral adaptations in response to environmental changes. Deletion of Ythdf1 in dopamine D1- or D2 receptor-expressing neurons selectively impaired D1- or D2-dependent learning, respectively, including both adaptive and maladaptive learning. This highlights YTHDF1 as a potential therapeutic target for preventing pathological plasticity. YTHDF1 recognizes m 6 A modifications on transcripts and regulates their translation. Elevated cAMP triggered increased protein synthesis in control striatal neurons but not in Ythdf1 -deficient neurons. Behaviorally, cell-type-specific Ythdf1 deletion resembled learning phenotypes caused by deletion of the m 6 A methyltransferase gene Mettl14 , suggesting YTHDF1 as the main mediator of m 6 A-dependent regulation in the striatum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, The University of Chicago, Chicago, IL 60637.
- Committee on Neurobiology, Biological Sciences Division, The University of Chicago, Chicago, IL 60637.
- Department of Chemistry, The University of Chicago, Chicago, IL 60637.
- Department of Human Genetics, The University of Chicago, Chicago, IL 60637.
- Byrd Alzheimer's Center and Research Institute, The University of South Florida, Tampa, FL 33613.
- Neuroscience Institute, Biological Sciences Division, The University of Chicago, Chicago, IL 60637.
ORCID-Profile: Kailong Wen, Wenqin Fu, Xiangbin Ruan, Shuai Wang, Xiaochang Zhang, Gopal Thinakaran, Chuan He, Xiaoxi Zhuang
Förderung
- NIDA NIH HHS
- HHS | NIH | National Institute on Drug Abuse (NIDA)
Zitieren
APA
Shi, Z., Wen, K., Fu, W., Zou, Z., Guo, K., Sammudin, N. H., Patel, M. J., Ruan, X., Sullere, S., Wang, S., Zhang, X., Thinakaran, G., He, C., & Zhuang, X. (2026). mRNA m 6 A modifications and the RNA-binding protein YTHDF1 affect translational control in both normal and pathological learning. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2518250123
Vancouver
Shi Z, Wen K, Fu W, Zou Z, Guo K, Sammudin NH, et al. mRNA m 6 A modifications and the RNA-binding protein YTHDF1 affect translational control in both normal and pathological learning. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2518250123
BibTeX
@article{Shi2026,
author = {Shi, Zhuoyue and Wen, Kailong and Fu, Wenqin and Zou, Zhongyu and Guo, Kathryn and Sammudin, Nabilah H and Patel, Meera J and Ruan, Xiangbin and Sullere, Shivang and Wang, Shuai and Zhang, Xiaochang and Thinakaran, Gopal and He, Chuan and Zhuang, Xiaoxi},
title = {mRNA m 6 A modifications and the RNA-binding protein YTHDF1 affect translational control in both normal and pathological learning},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2518250123}
}
EUVIMED